BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33605558)

  • 1. miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1.
    Wang J; Zhang M; Hu X; She J; Sun R; Qin S; Li D
    FEBS Open Bio; 2021 Jul; 11(7):1814-1826. PubMed ID: 33605558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1.
    Chou NH; Lo YH; Wang KC; Kang CH; Tsai CY; Tsai KW
    Anticancer Res; 2018 Jun; 38(6):3309-3318. PubMed ID: 29848678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-193b inhibits the proliferation, migration and invasion of gastric cancer cells via targeting cyclin D1.
    Wang L; Zhang Y; Zhao L; Liu S; Yu S; Ma Y; Sun G
    Acta Histochem; 2016 May; 118(4):323-30. PubMed ID: 27071318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    Zeng B; Shi W; Tan G
    BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression.
    He J; Ge Q; Lin Z; Shen W; Lin R; Wu J; Wang B; Lu Y; Chen L; Liu X; Zheng W; Zhang Y; Wang L; Wang K; Wang L; Zhuo W; Chen S
    FASEB J; 2020 Jun; 34(6):8544-8557. PubMed ID: 32356314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
    Song B; Du J; Song DF; Ren JC; Feng Y
    Biol Res; 2018 Nov; 51(1):44. PubMed ID: 30390708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer.
    Jiang L; Yang W; Bian W; Yang H; Wu X; Li Y; Feng W; Liu X
    Oncol Res; 2018 Dec; 27(1):19-27. PubMed ID: 29495973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.
    Fu Z; Xu Y; Chen Y; Lv H; Chen G; Chen Y
    Biomed Res Int; 2021; 2021():9121478. PubMed ID: 34840985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.
    Ma Z; Ma Y; Xia Q; Li Y; Li R; Chang W; Chen J; Leng Z; Tao K
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1201-12. PubMed ID: 26955820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of microRNA expression profiling studies in human gastric cancer.
    Shrestha S; Hsu SD; Huang WY; Huang HY; Chen W; Weng SL; Huang HD
    Cancer Med; 2014 Aug; 3(4):878-88. PubMed ID: 24902858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
    Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
    World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer.
    Zhao X; He L; Li T; Lu Y; Miao Y; Liang S; Guo H; Bai M; Xie H; Luo G; Zhou L; Shen G; Guo C; Bai F; Sun S; Wu K; Nie Y; Fan D
    Cell Death Differ; 2014 Dec; 21(12):1900-13. PubMed ID: 25080937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-3663-3p Inhibits the Progression of Gastric Cancer Through the CCND1 Pathway.
    Takao K; Konishi H; Matsubara D; Shoda K; Arita T; Shimizu H; Komatsu S; Shiozaki A; Yamamoto Y; Kubota T; Fujiwara H; Okamoto K; Otsuji E
    Anticancer Res; 2021 May; 41(5):2441-2449. PubMed ID: 33952469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-16 Modulates Melatonin-Induced Cell Growth in the Mouse-Derived Spermatogonia Cell Line GC-1 spg Cells by Targeting Ccnd1.
    Li C; Chen S; Li H; Chen L; Zhao Y; Jiang Y; Liu Z; Liu Y; Gao S; Wang F; Yu J; Wang H; Rao J; Zhou X
    Biol Reprod; 2016 Sep; 95(3):57. PubMed ID: 27465135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6.
    Hong SA; Lee S; Park J; Hong M; Yoon JS; Lee H; Lee JH; Kim S; Won HS; Kang K; Ko YH; Ahn YH
    Sci Rep; 2023 Oct; 13(1):17480. PubMed ID: 37838767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.